Abstract:OBJECTIVE:To evaluate the protective efficacy against a lethal dose of E. coli O157:H7 after intranasal, oral and subcutaneous immunization with the outer membrane protein (OMP) extracted from the whole cell of E. coli O157:H7.METHODS:Female BALB/C mice were immunized three times (on days 0, 7 and 14) with OMP and CT or Complete Frund adjuvant. On the 21st day after the last immunization, serum, fecal extracts and vaginal washes were collected for the detection of antigen-specific antibody responses by ELISA before the oral challenge with E. coli O157:H7 933. And the antigens that induced the specific antibody responses were analysed by Western-blotting. Then, the mice were orally challenged with 0.3 ml 4.25 x 10(10)/ml live E. coli O157:H7, and the mortality was recorded. On the 7th day after the challenge, the mice were sacrificed and the heart, liver, lung, kidney, small intestine and colon were collected. Then the histology lesions were observed by light microscopy.RESULTS:In ELISA, both intranasal and oral immunization, with CT as a mucosal adjuvant, induced strong anti-OMP IgA responses in serum, fecal extract and vaginal washes, and anti-OMP IgG responses in serum. However, the intranasal immunization was much more effective to induce specific IgA and IgG responses than the oral immunization. In contrast to mucosal immunization, subcutaneous immunization only induced high levels of specific IgG antibodies in serum, and did not effectively promote IgA immune response. The results of the protective efficacy after challenge showed that both intranasal and oral immunizations with OMP provided significant protection (86.7% to 40%, P < 0.01 and 73.3% to 40%, P < 0.05) against a lethal dose of E. coli O157:H7 challenge, and intranasal immunization possessed a better protective ability (86.7% to 73.3%, P < 0.05). In contrast, the mice immunized subcutaneously were not protected. They were died more early after oral challenge. Furthermore, the histopathological features of the kidney, colon and other organs also appeared to be well correlated with immunization route. In comparison with the mice immunized subcutaneously and those in control group, the severity of the histopathological lesions in the tissues of the mice immunized intranasally was minimal.CONCLUSION:These results suggested that the intranasal immunization should be the best choice of vaccine development against E. coli O157:H7.

Evaluation of the Immunization of Iron-Regulated Outer Membrane Proteins (IROMPs) of Leporid Pasteurella multocida in Mice Model

Primary Study on Common Antigens of Iron-Regulated Outer Membrane Proteins of Serotype 1 and 3 Pasteurella multocida Strains

Analysis of Leptospira Interrogans Ompa Gene and Immunological Identification of Its Recombinant Expression Product

Characterization of the ompL1 gene of pathogenic Leptospira species in China and cross-immunogenicity of the OmpL1 protein

Immune Protective Efficacy of China’s Traditional Inactivated and Attenuated Vaccines against the Prevalent Strains of Pasteurella multocida in Mice

Protective Efficacy and Immunologic Mechanism of the Recombinant Subunit Vaccine Against Actinobacillus Pleuropneumoniae in Mice

[Membrane Location and Naturally Antibody Responses of Genus-Specific Antigen OmpL1s of Leptospira Interrogans].

[The Study for the Immuno-Protection of E. Coli O157:H7 Outer Membrane Protein].

Diversity of Outer Membrane Protein Expression of Leptospira Interrogans During Infection of Human THP-1 Monocytes

Evaluation of Protective Effect of Multiantigenic DNA Vaccine Encoding MIC3 and ROP18 Antigen Segments of Toxoplasma Gondii in Mice.

Evaluation of multicomponent recombinant vaccines against Actinobacillus pleuropneumoniae in mice

Evaluation of Immunoprotective Effects of Fusobacterium necrophorum Outer Membrane Proteins 43K OMP, Leukotoxin and Hemolysin Multi-Component Recombinant Subunit Vaccine in Mice

[Immunoprotective Effects of Helicobacter Pylori UreB and HpaA Bivalence Recombinant Vaccine with Inner Adjuvant on Experimental Infection in Mice].

Characterization and Immunogenicity of Rlipl32/1-Lipl21-Ompl1/2 Fusion Protein As A Novel Immunogen for A Vaccine Against Leptospirosis

Chimeric Epitope Vaccine Against Leptospira Interrogans Infection and Induced Specific Immunity in Guinea Pigs

Comparative evaluation of a newly developed 13-valent pneumococcal conjugate vaccine in a mouse model

Attenuated vaccine PmCQ2Δ4555-4580 effectively protects mice against Pasteurella multocida infection

Immunogenicity of Pasteurella multocida and Mannheimia haemolytica outer membrane vesicles

Characterization and immunological effect of outer membrane vesicles from Pasteurella multocida on macrophages

HUMORAL IMMUNE RESPONSE AND PROTECTIVE EFFECT IN MICE INDUCED BY ORAL VACCINATION OF RECOMBINANT LACTOCOCCUS LACTIS EXPRESSING P30 OF TOXOPLASMA GONDII

The protective effect and immunomodulatory ability of orally administrated Lacticaseibacillus rhamnosus GG against Mycoplasma pneumoniae infection in BALB/c mice